Global Chronic obstructive pulmonary disease (COPD) and Asthma Devices Market to reach USD 51.62 billion by 2027.

Global COPD and Asthma Devices Market Size study, by Product Type (Inhalers and Nebulizers), by Indications (Asthma and Chronic Obstructive Pulmonary Disease (COPD)), by Distribution Channel (Retail Pharmacies, Hospitals and Online Pharmacies) and Regional Forecasts 2020-2027
Product Code:  HALMD_95949534
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	COPD and Asthma Devices Market, by Region, 2018-2027 (USD Billion)
1.2.2.	COPD and Asthma Devices Market, by Product Type, 2018-2027 (USD Billion)
1.2.3.	COPD and Asthma Devices Market, by Indication, 2018-2027 (USD Billion)
1.2.4.	COPD and Asthma Devices Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global COPD and Asthma Devices Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global COPD and Asthma Devices Market Dynamics	
3.1.	COPD and Asthma Devices Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global COPD and Asthma Devices Market: Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global COPD and Asthma Devices Market, by Product Type          
5.1.	Market Snapshot 
5.2.	Global COPD and Asthma Devices Market by Product Type, Performance - Potential Analysis
5.3.	Global COPD and Asthma Devices Market Estimates & Forecasts by Product Type 2017-2027 (USD Billion)
5.4.	COPD and Asthma Devices Market, Sub Segment Analysis
5.4.1.	 Inhalers
5.4.2.	Nebulizers
Chapter 6.	Global COPD and Asthma Devices Market, by Indication          
6.1.	Market Snapshot 
6.2.	Global COPD and Asthma Devices Market by Indication, Performance - Potential Analysis
6.3.	Global COPD and Asthma Devices Market Estimates & Forecasts by Indication 2017-2027 (USD Billion)
6.4.	COPD and Asthma Devices Market, Sub Segment Analysis
6.4.1.	 Asthma
6.4.2.	Chronic Obstructive Pulmonary Disease (COPD)
Chapter 7.	Global COPD and Asthma Devices Market, by Distribution Channel          
7.1.	Market Snapshot 
7.2.	Global COPD and Asthma Devices Market by Distribution Channel, Performance - Potential Analysis
7.3.	Global COPD and Asthma Devices Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)
7.4.	COPD and Asthma Devices Market, Sub Segment Analysis
7.4.1.	 Retail Pharmacies
7.4.2.	Hospitals
7.4.3.	Online Pharmacies
Chapter 8.	Global COPD and Asthma Devices Market, Regional Analysis
8.1.	COPD and Asthma Devices Market, Regional Market Snapshot 
8.2.	North America COPD and Asthma Devices Market 
8.2.1.1.	U.S. COPD and Asthma Devices Market 
8.2.1.2.	Product Type breakdown estimates & forecasts, 2017-2027
8.2.1.3.	Indication breakdown estimates & forecasts, 2017-2027
8.2.1.4.	Distribution Channel breakdown estimates & forecasts, 2017-2027
8.2.2.	Canada COPD and Asthma Devices Market
8.3.	Europe COPD and Asthma Devices Market Snapshot
8.3.1.	U.K. COPD and Asthma Devices Market 
8.3.2.	Germany COPD and Asthma Devices Market
8.3.3.	France COPD and Asthma Devices Market
8.3.4.	Spain COPD and Asthma Devices Market
8.3.5.	Italy COPD and Asthma Devices Market
8.3.6.	Rest of Europe COPD and Asthma Devices Market
8.4.	Asia-Pacific COPD and Asthma Devices Market Snapshot
8.4.1.	China COPD and Asthma Devices Market 
8.4.2.	India COPD and Asthma Devices Market 
8.4.3.	Japan COPD and Asthma Devices Market
8.4.4.	Australia COPD and Asthma Devices Market
8.4.5.	South Korea COPD and Asthma Devices Market
8.4.6.	Rest of Asia Pacific COPD and Asthma Devices Market
8.5.	Latin America COPD and Asthma Devices Market Snapshot
8.5.1.	Brazil COPD and Asthma Devices Market
8.5.2.	Mexico COPD and Asthma Devices Market
8.6.	Rest of The World COPD and Asthma Devices Market

Chapter 9.	Competitive Intelligence
9.1.	Top Market Strategies
9.2.	Company Profiles
9.2.1.	Aerogen, Inc. 
9.2.1.1.	Key Information
9.2.1.2.	Overview
9.2.1.3.	Financial (Subject to Data Availability)
9.2.1.4.	Product Summary
9.2.1.5.	Recent Developments
9.2.2.	 AstraZeneca PLC
9.2.3.	Baxter International Inc.
9.2.4.	Boehringer Ingelheim International GmbH
9.2.5.	3M COMPANY
9.2.6.	GF Health Products
9.2.7.	GlaxoSmithKline Plc
9.2.8.	Koninklijke Philips N.V.
9.2.9.	 Novartis AG
9.2.10.	PARI medical Holding GMBH
9.2.11.	Smith’s Group Plc.
Chapter 10.	Research Process
10.1.	Research Process
10.1.1.	Data Mining
10.1.2.	Analysis
10.1.3.	Market Estimation
10.1.4.	Validation
10.1.5.	Publishing
10.2.	Research Attributes
10.3.	Research Assumption

Global COPD and Asthma Devices Market is valued approximately at USD 36.9 billion in 2019 and is anticipated to grow with a growth rate of more than 4.3% over the forecast period 2020-2027. Chronic obstructive pulmonary disease (COPD) and asthma devices are permanent treatment or rescue therapy for respiratory diseases. The COPD and asthma are the respiratory diseases that cause difficulty in breathing and a blockage in the airways of the lungs because of the inflammation, mucus production, and tightening of muscles. The daily exposure to environmental pollution, portability of the drug delivery devices, rising population of active smokers and increasing government initiatives for COPD and Asthma Devices are the few factors responsible for growth of the market over the forecast period. For instance: according to the Forum of International Respiratory Societies (FIRS), around 384 million people suffer from chronic obstructive pulmonary disease (COPD) and 3 million die from it each year, thus making it the third leading cause of death worldwide. Moreover, increase in prevalence of respiratory diseases such as COPD, asthma, and emphysema, rise in need for rescue medication during sudden asthmatic attack and government initiatives towards the spread of awareness for COPD and asthma symptoms will create a lucrative demand for this market. Whereas, increase in price competition and deterioration of material quality and overall high cost of asthma treatment is a challenge for the patients is the major factor restraining the growth of global COPD and Asthma Devices market during the forecast period.

The regional analysis of global COPD and Asthma Devices market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world owing to the widespread and early adoption of inhalers & nebulizers and large pool of patients suffering from respiratory diseases. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:
Aerogen, Inc.
AstraZeneca PLC
Baxter International Inc.
Boehringer Ingelheim International GmbH
3M COMPANY
GF Health Products
GlaxoSmithKline Plc
Koninklijke Philips N.V.
Novartis AG
PARI medical Holding GMBH
Smith’s Group Plc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

by Product Type:
Inhalers
Nebulizers

by Indication:
Asthma
Chronic Obstructive Pulmonary Disease (COPD)

By Distribution Channel:
Retail Pharmacies
Hospitals
Online Pharmacies

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global COPD and Asthma Devices Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…